Mankind Pharma: Key entity reclassified from promoter to public category

Mankind Pharma Limited announced on September 2, 2025, that it has received approval from both BSE Limited and the National Stock Exchange of India Limited (NSE) for the reclassification of Ayushi and Poonam Estates LLP. This entity will transition from the "Promoter & Promoter Group" to the "Public" category, in accordance with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company submitted its application for this reclassification on August 3, 2025, to both exchanges. This move signifies a change in the ownership structure classification of Ayushi and Poonam Estates LLP within Mankind Pharma.

The approval letters, received from BSE and NSE on September 2, 2025, confirm the successful reclassification. The company will ensure compliance with subsequent relevant disclosures of material events related to this reclassification as per the applicable SEBI regulations.